During the past decade, Kiltearn Medical Centre conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Kiltearn Medical Centre" are "Prostate Cancer" (1 trials) and "Wounds" (1 trials). Many other conditions were trialed in "Kiltearn Medical Centre" in a lesser frequency.

Most popular intervention types in "Kiltearn Medical Centre" are "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Decapeptyl® SR 11.25mg; Prostap® 3 DCS 11.25mg; Zoladex® LA 10.8mg" (1 trials), "Decapeptyl® SR 22.5mg" (1 trials) and "PICO (single use portable negative pressure wound therapy)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kiltearn Medical Centre" are 1 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Kiltearn Medical Centre". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Kiltearn Medical Centre, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Kiltearn Medical Centre, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".